Yeungnam Univ J Med.  2000 Dec;17(2):137-145. 10.12701/yujm.2000.17.2.137.

The Role of Radiotherapy in Treatment of Hepatocellular Carcinoma

Affiliations
  • 1Department of Internal Medicine College of Medicine, Yeungnam University, Taegu Korea.
  • 2Department of Therapeutic Radiology and Oncology College of Medicine, Yeungnam University, Taegu Korea.

Abstract

BACKGROUND: Hepatocellular carcinomal(HCC) has been considered to be relatively radioresistant. The role of radiotherapy(RT) in the treatment of HCC is controversial. But RT has a role in the treatment of hepatocellular carcinoma as a single or combination modalities. The effect of radiotherapy on HCC was evaluated. Patients and METHODS: From January 1984 through January 2000, a total of 18 patients with unresectable HCC underwent radiotherapy alone or in conjunction with transarterial embolization(TAE). We reviewed the medical ecords of patients treated with RT and measured the tumor size using measured the tumor size using planimetry method. The Kaplan-Meier method was used to calculate the survival rate.
RESULTS
The RT patients were 15 men and 3 women. The mean age was 51 years. four(22.2%) of them were accompanied with ascites. Eleven(61.1%) of them were accompanied with liver cirrhosis and their functions were 6, 3, 2 in each Child-Pugh A, B, C, respectively. A partial response(PR) was observed in 2 patients(11.1%), minimal response(MR) in 4 patients (22.2%) and no change(NC), in 11 patients(61.1%), whereas progressive disease(PD) was seen in 1 patients(6%), respectively.
CONCLUSIONS
Although the radiotherapy in HCC did not improve the survival rate. it decreased the tmor size. Radiotherapy strengthens the therapeutic efficacy when combined with TAE, but more studies are needed.

Keyword

Radiotherapy; Hepatocellular carcinoma

MeSH Terms

Ascites
Carcinoma, Hepatocellular*
Female
Humans
Liver Cirrhosis
Male
Radiotherapy*
Survival Rate
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr